CN117355310A - 核糖醇治疗 - Google Patents
核糖醇治疗 Download PDFInfo
- Publication number
- CN117355310A CN117355310A CN202180073484.0A CN202180073484A CN117355310A CN 117355310 A CN117355310 A CN 117355310A CN 202180073484 A CN202180073484 A CN 202180073484A CN 117355310 A CN117355310 A CN 117355310A
- Authority
- CN
- China
- Prior art keywords
- day
- ribitol
- dose
- comprises administering
- method comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063076761P | 2020-09-10 | 2020-09-10 | |
| US63/076,761 | 2020-09-10 | ||
| PCT/US2021/049677 WO2022056137A1 (en) | 2020-09-10 | 2021-09-09 | Ribitol treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117355310A true CN117355310A (zh) | 2024-01-05 |
Family
ID=80629815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180073484.0A Pending CN117355310A (zh) | 2020-09-10 | 2021-09-09 | 核糖醇治疗 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230364118A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4210708A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023544249A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230069941A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117355310A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021338706A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3191582A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301088A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001881A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022056137A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10434113B2 (en) | 2016-12-16 | 2019-10-08 | The Charlotte Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| CN114269712A (zh) | 2019-05-28 | 2022-04-01 | 夏洛特-梅克伦堡医院管理局D/B/A艾奇恩健康 | 制备核糖醇的组合物和方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245235B2 (en) * | 2016-12-16 | 2019-04-02 | The Charlotte-Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| WO2020041750A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
-
2021
- 2021-09-09 MX MX2023001881A patent/MX2023001881A/es unknown
- 2021-09-09 CA CA3191582A patent/CA3191582A1/en active Pending
- 2021-09-09 EP EP21867600.5A patent/EP4210708A4/en active Pending
- 2021-09-09 KR KR1020237010497A patent/KR20230069941A/ko active Pending
- 2021-09-09 CN CN202180073484.0A patent/CN117355310A/zh active Pending
- 2021-09-09 US US18/044,747 patent/US20230364118A1/en active Pending
- 2021-09-09 AU AU2021338706A patent/AU2021338706A1/en active Pending
- 2021-09-09 WO PCT/US2021/049677 patent/WO2022056137A1/en not_active Ceased
- 2021-09-09 JP JP2023515723A patent/JP2023544249A/ja active Pending
- 2021-09-09 IL IL301088A patent/IL301088A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021338706A1 (en) | 2023-05-25 |
| WO2022056137A1 (en) | 2022-03-17 |
| US20230364118A1 (en) | 2023-11-16 |
| EP4210708A4 (en) | 2024-10-23 |
| WO2022056137A9 (en) | 2022-04-14 |
| JP2023544249A (ja) | 2023-10-23 |
| KR20230069941A (ko) | 2023-05-19 |
| CA3191582A1 (en) | 2022-03-17 |
| MX2023001881A (es) | 2023-04-03 |
| IL301088A (en) | 2023-05-01 |
| EP4210708A1 (en) | 2023-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12427161B2 (en) | Methods for treating and pharmaceutical compositions | |
| JP6387010B2 (ja) | 血中グルコースレベルを制御することによる糖尿病及び関連容態の処置のための組成物、方法及び使用 | |
| JP6381521B2 (ja) | ポンペ病の処置のための投与計画 | |
| CZ295567B6 (cs) | Tetrahydrolipstatin pro výrobu orálního farmaceutického prostředku pro ošetřování typu II diabetes mellitus | |
| TW201605434A (zh) | 使用半胱胺及其衍生物治療粒腺體疾病 | |
| WO2002028348A2 (en) | Compositions and methods for treatment of cystic fibrosis | |
| TW200808324A (en) | Method for shortening hospital stay in patients with congestive heart failure and acute fluid overload | |
| TW201713324A (zh) | Ado抗性半胱胺類似物及其用途 | |
| US20230364118A1 (en) | Ribitol treatment | |
| US20200061092A1 (en) | Methods and compositions for treating disorders associated with muscle weakness | |
| US20260076986A1 (en) | A combination of scyllo-inositol and flavones | |
| CN101677972A (zh) | 一种用于治疗神经变性疾病的奈拉美生的新组合物 | |
| US20180333399A1 (en) | Method of improving liver function | |
| WO2025212841A1 (en) | Compositions and methods for treating diseases and disorders associated with muscle weakness | |
| CN114053281B (zh) | 治疗慢性肾病的方法和药物组合物 | |
| WO2026013261A1 (en) | Nizubaglustat for use in the treatment of lysosomal storage disorders | |
| HK40058710A (en) | Dosing regimens for the treatment of pompe disease | |
| HK40112795A (en) | Dosing regimens for the treatment of pompe disease | |
| HK40058710B (en) | Dosing regimens for the treatment of pompe disease | |
| AU2014346703A1 (en) | Use of cysteamine and derivatives thereof to treat mitochondrial diseases | |
| WO2012154778A1 (en) | Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder | |
| MX2012014757A (es) | Composicion farmaceutica de una meglitinida y una tiazolidinediona o sus sales farmaceuticamente aceptables y su uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |